TY - JOUR
T1 - Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction
AU - Yamanaka, Tomoyuki
AU - Tosaki, Asako
AU - Miyazaki, Haruko
AU - Kurosawa, Masaru
AU - Furukawa, Yoshiaki
AU - Yamada, Mizuki
AU - Nukina, Nobuyuki
N1 - Funding Information:
This work was supported by Grant-in-Aid from Ministry of Education, Culture, Sports, Science and Technology of Japan [grant numbers 21700373, 17025044], the Ministry of Health, Welfare and Labour, Japan and RIKEN Special Postdoctoral Researchers Program. Funding to pay the Open Access publication charges for this article was provided by RIKEN Brain Science Institute.
PY - 2010/2/25
Y1 - 2010/2/25
N2 - In polyglutamine diseases including Huntington's disease (HD), mutant proteins containing expanded polyglutamine stretches form nuclear aggregates in neurons. Although analysis of their disease models suggested a significance of transcriptional dysregulation in these diseases, how it mediates the specific neuronal cell dysfunction remains obscure. Here we performed a comprehensive analysis of altered DNA binding of multiple transcription factors using R6/2 HD model mice brains that express an N-terminal fragment of mutant huntingtin (mutant Nhtt). We found a reduction of DNA binding of Brn-2, a POU domain transcription factor involved in differentiation and function of hypothalamic neurosecretory neurons. We provide evidence supporting that Brn-2 loses its function through two pathways, its sequestration by mutant Nhtt and its reduced transcription, leading to reduced expression of hypothalamic neuropeptides. In contrast to Brn-2, its functionally related protein, Brn-1, was not sequestered by mutant Nhtt but was upregulated in R6/2 brain, except in hypothalamus. Our data indicate that functional suppression of Brn-2 together with a regionspecific lack of compensation by Brn-1 mediates hypothalamic cell dysfunction by mutant Nhtt.
AB - In polyglutamine diseases including Huntington's disease (HD), mutant proteins containing expanded polyglutamine stretches form nuclear aggregates in neurons. Although analysis of their disease models suggested a significance of transcriptional dysregulation in these diseases, how it mediates the specific neuronal cell dysfunction remains obscure. Here we performed a comprehensive analysis of altered DNA binding of multiple transcription factors using R6/2 HD model mice brains that express an N-terminal fragment of mutant huntingtin (mutant Nhtt). We found a reduction of DNA binding of Brn-2, a POU domain transcription factor involved in differentiation and function of hypothalamic neurosecretory neurons. We provide evidence supporting that Brn-2 loses its function through two pathways, its sequestration by mutant Nhtt and its reduced transcription, leading to reduced expression of hypothalamic neuropeptides. In contrast to Brn-2, its functionally related protein, Brn-1, was not sequestered by mutant Nhtt but was upregulated in R6/2 brain, except in hypothalamus. Our data indicate that functional suppression of Brn-2 together with a regionspecific lack of compensation by Brn-1 mediates hypothalamic cell dysfunction by mutant Nhtt.
UR - http://www.scopus.com/inward/record.url?scp=77953499072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953499072&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddq087
DO - 10.1093/hmg/ddq087
M3 - Article
C2 - 20185558
AN - SCOPUS:77953499072
SN - 0964-6906
VL - 19
SP - 2099
EP - 2112
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 11
M1 - ddq087
ER -